ESOP Sale + Sec. 1042 Rollover: $20M Closely-Held Math

For owner-operators of profitable closely-held C-corporations, the IRC sec. 1042 ESOP rollover is the largest single-shot tax deferral available in the code. A $20 million sale produces roughly $4.71M of federal capital-gains tax at the 23.8 percent LTCG-plus-NIIT rate — and sec. 1042 lets that entire amount be deferred indefinitely if the seller reinvests in qualified replacement property within 12 months. Hold the QRP until death and the deferred gain is permanently eliminated by the sec. 1014 step-up. Few other transactions in the tax code offer this combination of immediate liquidity plus indefinite (and potentially permanent) deferral.

The rules are demanding. The ESOP must own at least 30 percent of the company after the sale. The company must be a C-corp. The seller's stock must have been held for three or more years. The QRP must be securities of US operating corporations meeting a passive-income test under sec. 1042(c)(4). The ESOP transaction must be priced by an independent ERISA fiduciary appraiser. And every step must be documented to withstand the DOL's aggressive ESOP enforcement posture. But for owner-operators with the right corporate form, the right time horizon, and the right exit-philosophy alignment with employees, sec. 1042 is the answer.

The sec. 1042 mechanics in one paragraph

Under IRC sec. 1042(a), if a taxpayer sells qualifying employer securities to an ESOP (or eligible worker-owned cooperative) and purchases qualified replacement property within 12 months, gain is not recognized to the extent of the QRP purchase price. The deferred gain is rolled into the QRP under sec. 1042(d) — the QRP's basis equals the original stock basis (so future sale of QRP triggers recognition of the deferred gain). If the QRP is held until death, the basis steps up to FMV under sec. 1014, and the deferred gain is eliminated.

The qualification rules under sec. 1042

Five conditions must be satisfied for sec. 1042 deferral:

• C-corporation status. The selling stockholder must hold stock of a domestic C-corporation. S-corps do not qualify. An S-corp owner can revoke the S-election and convert before the sale, but the C-corp conversion triggers built-in gains exposure under sec. 1374 for five years.
• Three-year holding period. The selling stockholder must have held the stock for at least three years. Stock acquired through gift or inheritance carries over the donor's holding period under sec. 1223.
• 30 percent post-sale ownership. The ESOP must own at least 30 percent of each class of outstanding employer stock immediately after the sale, or 30 percent of the total value of all outstanding employer securities.
• QRP reinvestment within 12 months. The seller must purchase qualified replacement property within 12 months of the ESOP sale date. The QRP purchase can occur as early as three months before the sale.
• QRP definition. Securities of US domestic operating corporations whose passive investment income did not exceed 25 percent of gross receipts in the year preceding the QRP purchase. Mutual funds, REITs, government securities, and securities of the same corporation are not QRP.

The 30 percent ownership rule — and why leveraged ESOPs solve it

The 30 percent threshold is the most common stumbling block for partial sales. A founder who wants to sell 25 percent of a company to an ESOP and keep 75 percent does not qualify for sec. 1042 — the ESOP fails the 30 percent test.

The leveraged ESOP solves this problem at scale. In a leveraged ESOP transaction, the ESOP borrows money (often guaranteed by the company, with the company contributing cash flow to amortize the loan over 5 to 10 years) to purchase a controlling or 100-percent block of the seller's stock. The 30 percent threshold is easily satisfied because the ESOP often owns 100 percent of the company post-transaction. The seller receives cash (from the borrowed amount), reinvests in QRP, and defers the entire gain.

The mechanics of a typical 100-percent leveraged ESOP:

1. The seller engages an ESOP financial advisor (e.g., GreatBanc, Argent, Reliance Trust) to structure the transaction
2. An independent appraiser (selected by the ESOP trustee) values the company at FMV
3. A bank lender (often with mezzanine financing) commits to a senior loan to the company; the company on-lends the proceeds to the ESOP under sec. 4975(d)(3)
4. The ESOP uses the loan proceeds to buy 100 percent of the seller's stock
5. The company makes annual contributions to the ESOP equal to the debt-service amount; these contributions are deductible under sec. 404(a)(9) and amortize the ESOP loan
6. As the loan is repaid, shares are released from the ESOP suspense account and allocated to participant accounts based on compensation

The seller walks away with $20M in cash, reinvests in QRP, and defers the entire capital gain. The company pays for the transaction over 5 to 10 years out of operating cash flow. The employees receive stock allocations as the loan is repaid, building retirement wealth in the company they helped grow.

What counts as qualified replacement property

QRP under sec. 1042(c)(4) is securities of US domestic operating corporations. The passive-income test: the issuer's passive investment income (interest, dividends, royalties, rents from non-operating real estate) must not exceed 25 percent of gross receipts in the year preceding the QRP purchase. This rules out holding companies, REITs, and BDCs.

Eligible QRP categories:

• Common stock of US operating corporations
• Preferred stock of US operating corporations
• Corporate bonds, debentures, and notes (including floating-rate notes — the most common QRP vehicle)
• Convertible securities of US operating corporations

Not eligible:

• Mutual funds and ETFs (the issuer test fails because the fund itself is not an operating corporation)
• REITs and BDCs (passive-income test fails)
• Government securities (Treasuries, agency debt, muni bonds)
• Bank deposits, CDs, money-market funds
• Foreign corporation securities
• Securities of the same corporation whose stock was sold to the ESOP

Most sec. 1042 sellers use ESOP-focused investment platforms (Prudential, US Bank, Lockwood, others) that build a portfolio of qualifying floating-rate corporate notes from large-cap US operating companies. The notes are issued at the seller's direction and can be customized to maturity ladders and credit quality preferences. Annual portfolio yields typically range from 3 to 6 percent depending on credit quality and rate environment.

The sec. 4978 10 percent excise tax — a backstop on ESOP sale stability

IRC sec. 4978 imposes a 10 percent excise tax on the company (not the seller) if the ESOP disposes of qualifying securities within three years of the sec. 1042 transaction, or if there is a reduction below 30 percent ownership through redemptions or new issuances. The tax applies to the amount realized on the disposition.

The point: Congress did not want sec. 1042 to be a one-day tax dodge. The ESOP must hold the stock for at least three years before any disposition, or the company pays an additional 10 percent excise tax. For most ESOPs the three-year hold is non-binding because the ESOP is structured as a long-term retirement plan, not a flip vehicle. But for any post-sale restructuring — a strategic sale of the company after the ESOP transaction, a recapitalization that triggers stock redemptions, a merger that disposes of the ESOP's stock — the three-year clock matters.

Worked example: $20M closely-held C-corp ESOP sale

Daniel founded Precision Manufacturing Inc., a Pennsylvania C-corp, in 2003 with $200,000 of capital. The company manufactures specialized industrial components, generates $4.5M of annual EBITDA, and has 65 employees. In 2026 Daniel is 62 and wants to retire. He considers three exit paths:

• Strategic stock sale to a competitor at $20M (no QSBS — company is too large now)
• Private equity recapitalization at $22M (PE wants Daniel to roll equity and stay on)
• Leveraged ESOP sale at $20M with sec. 1042 deferral

Path A: Strategic stock sale at $20M (no QSBS)

• Sale price: $20,000,000
• Basis: $200,000
• Capital gain: $19,800,000
• Federal tax at 23.8% (20% LTCG + 3.8% NIIT): $4,712,400
• Pennsylvania tax at 3.07% (PA does not have separate LTCG rate): $607,860
• Net to Daniel: $14,679,740
• Effective rate: 26.6%

Path B: PE recapitalization at $22M (60% cash, 40% rollover equity)

• Cash at closing: $13,200,000 (60% of $22M)
• Rollover equity: $8,800,000 (40% of $22M, tax-deferred under sec. 351 rollover)
• Cash gain: $13,200,000 − $120,000 allocated basis = $13,080,000
• Federal tax at 23.8%: $3,113,040
• Pennsylvania tax at 3.07%: $401,556
• Net cash after tax: $9,685,404
• Plus $8.8M of rollover equity (taxable at future exit)
• Daniel stays as Executive Chairman for 3 years; PE targets a 5-year exit at $40M-$60M valuation

Path C: Leveraged ESOP sale at $20M with sec. 1042 deferral

• Sale price: $20,000,000
• Capital gain: $19,800,000
• Sec. 1042 deferral: 100% — Daniel reinvests $20M in QRP within 12 months
• Federal tax at closing: $0
• Pennsylvania state conformity to sec. 1042: PA does conform — state tax also $0
• Net to Daniel: $20,000,000 (invested in QRP, basis carryover of $200K)
• If QRP held until death: sec. 1014 step-up eliminates the $19.8M deferred gain permanently
• If QRP sold during life: deferred gain recognized at the time of sale

Side-by-side comparison (net immediate cash)

• Path A (strategic stock sale): $14,679,740 after federal and state tax
• Path B (PE recap, cash portion): $9,685,404 immediate cash, $8.8M deferred equity (taxable at future exit)
• Path C (ESOP sec. 1042): $20,000,000 in QRP, $0 immediate tax, gain deferred indefinitely

Path C produces $5.3M more net wealth than Path A — and if QRP is held until death, the entire $4.71M of deferred federal tax plus $608K of state tax is permanently eliminated. The catch: Path C requires Daniel to invest $20M into QRP and hold it (at least until the QRP portfolio matures or until death) to maintain the deferral.

Cumulative value if QRP held 20 years and stepped up at death

• QRP portfolio at 4% net yield over 20 years: $20M × (1.04)^20 = $43.8M
• Original basis in QRP: $200K (carried over from PMC stock)
• Sec. 1014 step-up at death: basis resets to $43.8M FMV
• Permanent elimination of deferred gain: $19,800,000 of capital gain wiped out
• Tax permanently avoided: $4,712,400 federal + $607,860 PA = $5,320,260

The non-tax considerations

Sec. 1042 is a powerful tax tool, but the ESOP structure has non-tax trade-offs that matter:

• Liquidity discount in the sale price. ESOP appraisals reflect FMV, but the ESOP is a financial buyer that cannot pay strategic synergies. The ESOP price is usually 10 to 20 percent below what a strategic buyer would pay. On a $20M ESOP sale, Daniel may have left $2M to $5M on the table relative to a strategic exit. The sec. 1042 deferral has to be large enough to overcome this gap — for high-basis owners, it often does not.
• Ongoing company financial risk. The leveraged ESOP loan is typically guaranteed by the company. If the company underperforms post-sale, the debt-service obligation can strain operations. For mature, cash-flow-stable businesses, this risk is manageable; for growth-stage businesses with volatile cash flow, the leverage can be dangerous.
• Repurchase obligation. When ESOP participants retire, are terminated, or die, the company is generally required to repurchase their vested ESOP shares. This creates a long-tail liability that compounds over decades and must be modeled into post-sale company finances.
• QRP concentration and illiquidity. Once $20M is invested in QRP, the seller is locked in — selling QRP triggers the deferred gain. This means the seller cannot rebalance into mutual funds, ETFs, or non-QRP investments during their lifetime without paying the deferred tax. Estate planning, charitable giving, and asset diversification all become constrained.
• DOL enforcement risk. The DOL aggressively litigates ESOP overvaluation cases. Even with an independent appraiser, the seller faces potential litigation exposure for 5 to 10 years post-sale if employee participants or the DOL challenge the valuation.

When sec. 1042 is the right answer

Sec. 1042 ESOP sales work best for:

• Owner-operators of profitable C-corporations with $5M to $100M of EBITDA
• Companies with stable cash flow that can support 5-to-10-year leveraged loan amortization
• Owners with low stock basis (so the deferral is large in absolute terms)
• Owners aged 55-plus who plan to hold QRP until death and benefit from the sec. 1014 step-up
• Owners who prefer a slow exit (employees buying the company) over a quick sale to a strategic or PE buyer
• Companies where employees are aligned with the long-term mission and willing to take on the leveraged-buyout structure

Sec. 1042 generally does not work for:

• S-corp owners (would require C-corp conversion plus five years of BIG exposure)
• Companies with volatile cash flow that cannot support the ESOP loan
• Owners who need diversification and rebalancing flexibility during life
• Owners under age 50 (sec. 1014 step-up is too far in the future to outweigh QRP concentration cost)
• Companies seeking maximum strategic-buyer premium

Key takeaways

• IRC sec. 1042 lets an owner of a closely-held C-corp defer 100 percent of federal capital-gains tax on a sale to an ESOP, if the ESOP owns 30 percent or more post-sale and the seller reinvests proceeds in QRP within 12 months. On a $20M sale that is $4.71M of federal tax deferred.
• QRP under sec. 1042(c)(4) is securities of US operating corporations meeting a 25 percent passive-income test. Mutual funds, REITs, government securities, and foreign issuers do not qualify. Most sellers use floating-rate corporate notes through specialized ESOP investment platforms.
• The 30 percent threshold is satisfied most easily through a leveraged ESOP that buys 100 percent of the company in a single transaction financed by company-guaranteed debt amortized over 5 to 10 years.
• The sec. 1042 deferral becomes a true exclusion if QRP is held until death — the sec. 1014 step-up eliminates the deferred gain permanently. Combined with a 20-year QRP hold and 4 percent yield compounding, the value of the deferred tax can compound to $5M-plus on a $20M closely-held sale.
• The non-tax trade-offs (10 to 20 percent valuation discount versus strategic buyer, ongoing company financial risk from leveraged ESOP loan, QRP illiquidity, DOL enforcement exposure) determine whether the sec. 1042 strategy is the right fit. For owner-operators of profitable C-corps with stable cash flow and a long-term mission alignment with employees, sec. 1042 is usually the largest single tax-deferral tool in the IRC.
• S-corp owners do not qualify for sec. 1042 without converting to C-corp and waiting through the five-year BIG period under sec. 1374. The conversion math rarely works for distributing S-corps.